Next Article in Journal
T1-MRI Fluorescent Iron Oxide Nanoparticles by Microwave Assisted Synthesis
Next Article in Special Issue
Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge
Previous Article in Journal
Structural Stability of Diffusion Barriers in Cu/Ru/MgO/Ta/Si
Previous Article in Special Issue
Iron Oxide Nanoparticles Coated with a Phosphorothioate Oligonucleotide and a Cationic Peptide: Exploring Four Different Ways of Surface Functionalization
Open AccessReview

Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?

UCIBIO, Department of Life Sciences, Faculdade de Ciências e Tecnologia, Campus Caparica, 2829-516 Caparica, Portugal
Author to whom correspondence should be addressed.
Academic Editor: Subramanian Tamil Selvan
Nanomaterials 2015, 5(4), 1853-1879;
Received: 22 August 2015 / Revised: 4 October 2015 / Accepted: 27 October 2015 / Published: 3 November 2015
(This article belongs to the Special Issue Nanoparticles in Theranostics)
Nanoparticles have been making their way in biomedical applications and personalized medicine, allowing for the coupling of diagnostics and therapeutics into a single nanomaterial—nanotheranostics. Gold nanoparticles, in particular, have unique features that make them excellent nanomaterials for theranostics, enabling the integration of targeting, imaging and therapeutics in a single platform, with proven applicability in the management of heterogeneous diseases, such as cancer. In this review, we focus on gold nanoparticle-based theranostics at the lab bench, through pre-clinical and clinical stages. With few products facing clinical trials, much remains to be done to effectively assess the real benefits of nanotheranostics at the clinical level. Hence, we also discuss the efforts currently being made to translate nanotheranostics into the market, as well as their commercial impact. View Full-Text
Keywords: nanotheranostics; diagnostics; targeted therapy; cancer; gold nanoparticles; precision medicine; theranostics nanotheranostics; diagnostics; targeted therapy; cancer; gold nanoparticles; precision medicine; theranostics
Show Figures

Figure 1

MDPI and ACS Style

Pedrosa, P.; Vinhas, R.; Fernandes, A.; Baptista, P.V. Gold Nanotheranostics: Proof-of-Concept or Clinical Tool? Nanomaterials 2015, 5, 1853-1879.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop